Evidence map›Paper›PMID 38374354›Full record

ArticleScientific reports2024

Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia.

Elsa Tesfaye, Birhanu Kumbi, Belayihun Mandefro, Yadesa Hemba, Krushna Kant Prajapati, Suresh Chandra Singh, Vijay Upadhye, Sunil Tulshiram Hajare

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Elsa TesfayeDepartment of Biology, Faculty of Biomedical Science, College of Natural and Computational Sciences, Dilla University, SNNPR, 419, Dilla, Ethiopia.
Birhanu KumbiDepartment of Biology, Faculty of Biomedical Science, College of Natural and Computational Sciences, Dilla University, SNNPR, 419, Dilla, Ethiopia.
Belayihun MandefroDepartment of Biology, Faculty of Biomedical Science, College of Natural and Computational Sciences, Dilla University, SNNPR, 419, Dilla, Ethiopia.
Yadesa HembaDepartment of Biology, Faculty of Biomedical Science, College of Natural and Computational Sciences, Dilla University, SNNPR, 419, Dilla, Ethiopia.
Krushna Kant PrajapatiShri Krishna Pathology and ELISA Laboratory, Sumerpur, India.
Suresh Chandra SinghTB and COVID Antigen Development Centre, Vadodara, Gujarat, India.
Vijay UpadhyeResearch & Development cell, Institute of Applied Sciences,Parul University, Vadodara, Gujarat, India.
Sunil Tulshiram HajareDepartment of Biology, Faculty of Biomedical Science, College of Natural and Computational Sciences, Dilla University, SNNPR, 419, Dilla, Ethiopia. sunilhajare@gmail.com.ORCID 0000-0002-6118-9471
Dilla University · ETKM Shah Dental College and Hospital · INParul University · INShree Krishna Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomaviruses (HPVs) are circular, nonenveloped small double-stranded DNA viruses that infect stratified epithelium and can cause a number of life-threatening diseases. HPV is the central risk factor for developing cervical cancer and is estimated that approximately 98% of this disease is associated with oncogenic types of HPV. HPV infection leads to an estimated 266,000 cervical cancer deaths annually. Therefore, the objective of this study was to determine the prevalence of HPV infection and risk factors associated with cervical lesion among women attending the cervical cancer screening clinic at the Ethiopian Family Guidance Association, Addis Ababa. A cross-sectional study was conducted to determine the prevalence of HPV infection. Data were collected using a questionnaire and samples leftover from cervical screening were taken. The leftover swab was air dried and DNA was extracted and amplified by using a PCR. A total of 247 women were included in the study. The prevalence of HPV was 9.72% among the population studied. Of all participants, 27.13% were positive for cervical intraepithelial neoplasia-1 (CIN1). CIN1 positivity was found in half of HPV positive women. Among HPV positive women, half of them had started sexual intercourse at ages 12-17 years and 41.66% were women who gave birth at ages 12-17 years. The high prevalence of HPV and the CIN1 positive group were ages 36-57 and women with multiple sexual partners. The other groups with the highest CIN1 positive were 22.39% grade (9-12) and 20.9% primary (1-8) and uneducated women. Among HPV positive women, 83.33% had an abortion history and 80% miscarried in the first trimester. Among the CIN1 positives, 53.73% had more than two sexual partners. Among HPV positive women, half of them were users of contraception methods. In conclusion, the highest prevalence of HPV is among women who began sexual intercourse earlier and who gave birth at 12-17 years of age, have an abortion history, with MSP and oral contraceptive methods users. In addition to HPV, early pregnancy and sexual intercourse at 12-17 years of age, abortion, MSP, and oral hormonal contraceptives are factors in cervical cancer. Finally, most women do not have enough knowledge and awareness about cervical cancer and the risk factor.

Indexed as

Papillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsContraceptives, OralCross-Sectional StudiesEarly Detection of CancerEthiopiaFemaleHumansPapillomaviridaePrevalenceRisk FactorsContraceptives, OralCervical cancerCINHPVPCRRisk factorsWomen

Identifiers

PMID38374354
PMCPMC10876560
OpenAlexW4391932148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.